Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme.

Multiple sclerosis journal - experimental, translational and clinical·2024
Same author

Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.

European journal of neurology·2019
Same author

Comparing longitudinal brain atrophy measurement techniques in a real-world multiple sclerosis clinical practice cohort: towards clinical integration?

Therapeutic advances in neurological disorders·2019
Same author

The evolution of "No Evidence of Disease Activity" in multiple sclerosis.

Multiple sclerosis and related disorders·2018
Same author

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.

Journal of neuroimmunology·2017
Same author

Neurological deficit following stereotactic radiosurgery for trigeminal neuralgia.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2016
Same journal

American academy of neurology annual meeting.

International MS journal·2011
Same journal

Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.

International MS journal·2011
Same journal

The clinical usefulness of routine MRI assessment.

International MS journal·2011
Same journal

Acute Psychosis as the Initial Presentation of MS: A Case Report.

International MS journal·2011
Same journal

Russell Brains Review of MS.

International MS journal·2011
Same journal

Epstein-Barr Virus and MS:Causality or Association?

International MS journal·2011
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

MS: is it one disease?

M H Barnett1, J D E Parratt, J D Pollard

  • 1Institute of Clinical Neurosciences, University of Sydney, New South Wales, Australia. mbarnett@mail.usyd.edu.au

International MS Journal
|August 13, 2009
PubMed
Summary
This summary is machine-generated.

Early multiple sclerosis (MS) lesions may stem from a single evolving process, not distinct pathways. Research suggests a uniform pre-phagocytic pathology challenges previous subtype classifications.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: Jun 21, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

  • Neuroimmunology
  • Neuropathology

Background:

  • Established views of multiple sclerosis (MS) pathogenesis focus on inflammatory demyelination mediated by macrophages and CD4+ T helper 1 (Th1) cells.
  • Recent findings emphasize the role of innate immune cells, humoral factors, CD8+ T cells, and regulatory T cells in MS.
  • Comparisons with experimental allergic encephalomyelitis have historically informed MS models, but may oversimplify human disease complexity.

Purpose of the Study:

  • To re-evaluate the prevailing model of multiple sclerosis (MS) lesion formation.
  • To investigate the heterogeneity observed in active MS lesions and its implications for disease pathogenesis.
  • To critically assess a proposed classification of four distinct early MS lesion subtypes.

Main Methods:

  • Histopathological examination of actively demyelinating lesions in multiple sclerosis (MS) autopsy and biopsy tissue.
  • Analysis of lesion subtypes to determine their exclusivity within individual patients.
  • Comparative analysis of findings with existing models of MS pathogenesis.

Main Results:

  • A proposed schema of four mutually exclusive early MS lesion subtypes has been questioned.
  • Evidence suggests a uniform pre-phagocytic pathology across different lesion types.
  • Overlap of lesion subtypes within individual patients with relapsing-remitting MS was observed.
  • Findings challenge the notion of disparate pathogenetic pathways for clinically similar MS syndromes.

Conclusions:

  • Heterogeneous features in active MS lesions likely represent stages of a single evolving pathophysiological process.
  • The classification of distinct, mutually exclusive early MS lesion subtypes requires further independent verification.
  • Genetic factors may contribute to variations within this unified disease process.